Cargando…
Type I interferon: From innate response to treatment for COVID‐19
Effective prophylactic and therapeutic interventions are urgently needed to address the coronavirus disease 2019 (COVID‐19) pandemic. Various antiviral drugs have recently been tested. Type I interferon (IFN) is a regulatory protein involved in the innate immune response, with broad‐spectrum antivir...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768291/ https://www.ncbi.nlm.nih.gov/pubmed/33376955 http://dx.doi.org/10.1002/ped4.12226 |